Theragen Etex Co.Ltd (066700) - Total Liabilities
Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has total liabilities worth ₩100.25 Billion KRW (≈ $67.94 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 066700 cash flow conversion to assess how effectively this company generates cash.
Theragen Etex Co.Ltd - Total Liabilities Trend (2005–2024)
This chart illustrates how Theragen Etex Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Theragen Etex Co.Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Theragen Etex Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Theragen Etex Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Daelim B&Co
KO:005750
|
Korea | ₩171.13 Billion |
|
Highlight Communications AG
XETRA:HLG
|
Germany | €481.59 Million |
|
IG Group Holdings PLC
LSE:IGG
|
UK | GBX1.22 Billion |
|
GCL Global Holdings Ltd Ordinary Shares
NASDAQ:GCL
|
USA | $123.85 Million |
|
Minda Global Bhd
KLSE:5166
|
Malaysia | RM261.50 Million |
|
JAG Bhd
KLSE:0024
|
Malaysia | RM117.84 Million |
|
Herige SA
PA:ALHRG
|
France | €191.51 Million |
|
Ama Marine Public Company Limited
BK:AMA
|
Thailand | ฿1.28 Billion |
Liability Composition Analysis (2005–2024)
This chart breaks down Theragen Etex Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Theragen Etex Co.Ltd (066700) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Theragen Etex Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Theragen Etex Co.Ltd (2005–2024)
The table below shows the annual total liabilities of Theragen Etex Co.Ltd from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩106.46 Billion ≈ $72.15 Million |
+18.02% |
| 2023-12-31 | ₩90.20 Billion ≈ $61.13 Million |
-12.39% |
| 2022-12-31 | ₩102.95 Billion ≈ $69.77 Million |
-19.17% |
| 2021-12-31 | ₩127.38 Billion ≈ $86.32 Million |
-20.77% |
| 2020-12-31 | ₩160.76 Billion ≈ $108.95 Million |
+52.19% |
| 2019-12-31 | ₩105.64 Billion ≈ $71.59 Million |
+12.67% |
| 2018-12-31 | ₩93.76 Billion ≈ $63.54 Million |
+60.28% |
| 2017-12-31 | ₩58.50 Billion ≈ $39.64 Million |
-15.04% |
| 2016-12-31 | ₩68.85 Billion ≈ $46.66 Million |
-0.36% |
| 2015-12-31 | ₩69.10 Billion ≈ $46.83 Million |
+58.15% |
| 2014-12-31 | ₩43.69 Billion ≈ $29.61 Million |
+5.81% |
| 2013-12-31 | ₩41.29 Billion ≈ $27.98 Million |
-1.80% |
| 2012-12-31 | ₩42.05 Billion ≈ $28.50 Million |
-4.44% |
| 2011-12-31 | ₩44.01 Billion ≈ $29.82 Million |
-9.93% |
| 2010-12-31 | ₩48.86 Billion ≈ $33.11 Million |
+13.96% |
| 2009-12-31 | ₩42.87 Billion ≈ $29.06 Million |
-10.12% |
| 2008-12-31 | ₩47.70 Billion ≈ $32.33 Million |
+38.98% |
| 2007-12-31 | ₩34.32 Billion ≈ $23.26 Million |
+10.18% |
| 2006-12-31 | ₩31.15 Billion ≈ $21.11 Million |
-12.93% |
| 2005-12-31 | ₩35.78 Billion ≈ $24.25 Million |
-- |
About Theragen Etex Co.Ltd
Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company wa… Read more